Nimacimab (Anti-CB1 / CNR1)

Nimacimab (Anti-CB1/CNR1) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases. MW:145.5 KD.
Supplier Selleck Chemicals
Product # A2574
Sku # A2574-1mg
Pricing 1mg, $270.00
Feedback